Damien Hancox, Co-Founder of SpectrumX joins Proactive London's Katie Pilbeam to explain their work with proprietary formulations of HOCL (Hypochlorous Acid).
Most recently, the firm revealed lab tests results showing its inhaled Covid treatment to be efficacious against the virus and its mutations, including the now-dominant delta variant.
For the next step at the University Hospital Innsbruck, 240 patients will take part in the Phase II double-blind placebo-controlled evaluation of the potential breakthrough in the fight against COVID-19.